resebidrag France
| Reference number | |
| Coordinator | DOUBLE BOND PHARMACEUTICALS AB - Double Bond Pharmaceutical AB |
| Funding from Vinnova | SEK 10 000 |
| Project duration | November 2017 - January 2018 |
| Status | Completed |
| Venture | Travel grant |
| Call | Travel grant for building international consortia |
Purpose and goal
Information about Double Bond Pharmaceutical and products Temodex SA033 was presented for potential partners (Ipsen and Servier) as well as VC companies (like for example Industriefonden)
Expected results and effects
The meetings were in accordance to the plan
Planned approach and implementation
The meetings were in accordance to the plan